Published: Thursday, May 15, 2025 · 9:30 AM | Updated: Thursday, May 15, 2025 · 9:30 AM
📊 518 views
- Marcus Borenäs and Elizabeth Schepke awarded the 2025 Assar Gabrielsson Foundation Prizes.
- Each researcher receives SEK 100,000 for their contributions in cancer research.
- The foundation supports early-stage promising cancer research lacking major funding.
The Assar Gabrielsson Foundation, established in 1962 by Volvo co-founder Assar Gabrielsson, has announced the recipients of its prestigious 2025 prizes. Marcus Borenäs has been recognized in the basic science research category for his groundbreaking work on malignant neuroblastomas in children, and Elizabeth Schepke has been acknowledged in the clinical research category for her studies on DNA methylation in pediatric brain tumors.
Both recipients have been awarded SEK 100,000 each in research grants. These grants are administered by the Sahlgrenska Academy at the University of Gothenburg to support the further advancement of their respective studies. The foundation primarily endorses promising early-stage cancer research projects that have not yet secured significant funding from major research funds.
Marcus Borenäs’s research focuses on understanding ALK signaling in various types of neuroblastomas, a type of cancer that develops in the sympathetic nervous system. This research could potentially lead to the development of more effective treatments for neuroblastomas in children. Meanwhile, Elizabeth Schepke’s studies on DNA methylation in pediatric brain tumors aim to improve the classification of these tumors, thereby aiding in the selection of the most appropriate treatment strategies.
Volvo, listed under the stock ticker VLVLY, continues its commitment to advancing scientific research, with the Assar Gabrielsson Foundation playing a pivotal role in fostering breakthroughs in cancer research since its inception. The foundation’s support exemplifies Volvo’s dedication to leveraging its legacy for impactful and sustainable development in healthcare and scientific innovation.
MORE IN INSIDE INVESTMENT NEWS
Carrefour Shares Plunge 14%: Navigating European Retail Volatility
Published: Wednesday, October 21, 2026 · 6:29 AM
Netflix Earnings: Alpha Bet on Streaming’s Rebound?
Published: Tuesday, October 20, 2026 · 12:45 PM
